GlassScriptPhysician profile
Nathaniel M Cook
NPI 1487903472
$876.52
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.56 · 2022: $498 · 2023: $215 · 2024: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296 · Education: $26.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.81 |
| Education | $26.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $124.36 | 2022-2024 | Keytruda |
| Amgen INC. | $107.81 | 2022-2023 | Nplate, Xgeva, Vectibix |
| Seagen INC. | $101.72 | 2022-2023 | Adcetris, Padcev |
| E.R. Squibb & Sons, L.L.C. | $78.14 | 2022-2023 | Opdivo |
| Celgene Corporation | $49.25 | 2022 | |
| Novartis Pharmaceuticals Corporation | $47.95 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $47.41 | 2022 | |
| Exelixis INC. | $40.32 | 2019 | |
| Abbvie INC. | $33.38 | 2022 | |
| Adc Therapeutics America, INC. | $28.54 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $27.31 | 2023 | Libtayo |
| Gilead Sciences, INC. | $25.71 | 2022 | |
| Taiho Oncology, INC. | $25.21 | 2023 | |
| Incyte Corporation | $24.98 | 2022 | |
| Daiichi Sankyo INC. | $23.06 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | $17.47 | 2024 | Clonoseq |
| Lilly USA, LLC | $16.24 | 2019 | |
| Karyopharm Therapeutics INC. | $15.83 | 2023 | Xpovio |
| Tersera Therapeutics LLC | $14.37 | 2022 | |
| Genentech USA, INC. | $14.37 | 2022 | |
| Cti Biopharma Corp. | $13.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.